Ibrahim B. Dagher
Director · BRAINSTORM CELL THERAPEUTICS INC.
Individual
- 2026
- May 20, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Ibrahim B. Dagher. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chaim Lebovits - $11K in BCLI purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ibrahim B. Dagher?
Ibrahim B. Dagher is a corporate insider, tracked as Director of BRAINSTORM CELL THERAPEUTICS INC. (BCLI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ibrahim B. Dagher last file a Form 4?
The only primary Form 4 on record is dated 20 May 2026.